ArticlebioRxiv : the preprint server for biology2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.
Parker J Jamieson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.